Empagliflozin Effects Subside With Discontinuation

Patients with broad range of kidney function show reduced effects following discontinuation after EMPA-KIDNEY trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/empagliflozin-effects-subside-discontinuation-2024a1000jm9?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost